June 15, 2015
Carna Biosciences, a Kobe-based drug discovery startup, said on June 11 that it has entered into a worldwide exclusive licensing deal with Janssen Biotech for its small molecule protein kinase inhibitor - the first licensing accord for its proprietary product...read more